The triplet regimen of azacitidine, venetoclax, and tagraxofusp showed high complete response rates in both untreated and relapsed/refractory BPDCN patients. Safety profile of the triplet was ...

Staying alert, taking a moment to research unfamiliar sellers or offers, and approaching deals that seem too good to be true ...

Strong winds will develop Tuesday morning and continue into the evening for many. Gusts up to 70 mph will be possible for ...